vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $66.7M, roughly 1.2× RMR GROUP INC.). RMR GROUP INC. runs the higher net margin — 18.3% vs -38.1%, a 56.3% gap on every dollar of revenue. On growth, RMR GROUP INC. posted the faster year-over-year revenue change (40.8% vs 20.2%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

PRCT vs RMR — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.2× larger
PRCT
$83.1M
$66.7M
RMR
Growing faster (revenue YoY)
RMR
RMR
+20.6% gap
RMR
40.8%
20.2%
PRCT
Higher net margin
RMR
RMR
56.3% more per $
RMR
18.3%
-38.1%
PRCT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
PRCT
PRCT
RMR
RMR
Revenue
$83.1M
$66.7M
Net Profit
$-31.6M
$12.2M
Gross Margin
64.9%
Operating Margin
-4.1%
48.1%
Net Margin
-38.1%
18.3%
Revenue YoY
20.2%
40.8%
Net Profit YoY
-27.9%
91.1%
EPS (diluted)
$-0.56
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
RMR
RMR
Q1 26
$83.1M
Q4 25
$76.4M
$66.7M
Q3 25
$83.3M
Q2 25
$79.2M
Q1 25
$69.2M
Q4 24
$68.2M
Q3 24
$58.4M
Q2 24
$53.4M
Net Profit
PRCT
PRCT
RMR
RMR
Q1 26
$-31.6M
Q4 25
$-29.8M
$12.2M
Q3 25
$-21.4M
Q2 25
$-19.6M
Q1 25
$-24.7M
Q4 24
$-18.9M
Q3 24
$-21.0M
Q2 24
$-25.6M
Gross Margin
PRCT
PRCT
RMR
RMR
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
RMR
RMR
Q1 26
-4.1%
Q4 25
-40.6%
48.1%
Q3 25
-27.8%
Q2 25
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Net Margin
PRCT
PRCT
RMR
RMR
Q1 26
-38.1%
Q4 25
-39.1%
18.3%
Q3 25
-25.7%
Q2 25
-24.7%
Q1 25
-35.8%
Q4 24
-27.6%
Q3 24
-35.9%
Q2 24
-48.0%
EPS (diluted)
PRCT
PRCT
RMR
RMR
Q1 26
$-0.56
Q4 25
$-0.54
$0.71
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$245.6M
$49.3M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$232.7M
Total Assets
$487.1M
$687.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
RMR
RMR
Q1 26
$245.6M
Q4 25
$286.5M
$49.3M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
PRCT
PRCT
RMR
RMR
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
RMR
RMR
Q1 26
$347.7M
Q4 25
$365.9M
$232.7M
Q3 25
$380.3M
Q2 25
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
Total Assets
PRCT
PRCT
RMR
RMR
Q1 26
$487.1M
Q4 25
$508.1M
$687.1M
Q3 25
$511.5M
Q2 25
$513.1M
Q1 25
$519.4M
Q4 24
$534.0M
Q3 24
$374.1M
Q2 24
$374.4M
Debt / Equity
PRCT
PRCT
RMR
RMR
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
RMR
RMR
Operating Cash FlowLast quarter
$10.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
RMR
RMR
Q1 26
Q4 25
$-10.3M
$10.7M
Q3 25
$-6.6M
Q2 25
$-15.0M
Q1 25
$-17.0M
Q4 24
$-32.4M
Q3 24
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
PRCT
PRCT
RMR
RMR
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
PRCT
PRCT
RMR
RMR
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
PRCT
PRCT
RMR
RMR
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
PRCT
PRCT
RMR
RMR
Q1 26
Q4 25
0.88×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons